MEDICAL ADVOCATES
 IDUs
  Hepatitis C

 General Reports
Pathogenesis
 National Studies
 Prevention
Diagnosis/Monitoring/Screening/Testing
Clinical Management
Drugs
HIV/HCV Coinfection


 
IDU Disease Main Page Main New/Newsworthy  Home Page
Last Update:  May 12, 2012   
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
       
         Journal Papers, Abstracts, and Commentaries
 
 
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting
drug users: towards a vaccine.
Grebely J, Prins M, Hellard M,  et al
Lancet Infect Dis. 2012 May;12(5):408-414
 Abstract

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level
and rapid HVR1 evolution.
 Liu L, Fisher BE, Thomas DL, et al
Hepatology. 2012 Jan 11.
 Abstract

Meta-Analysis of Hepatitis C Seroconversion in Relation to Shared Syringes and Drug Preparation Equipment.
Pouget ER, Hagan H, Des Jarlais DC.
Addiction. 2011 Dec 13.
Abstract

Hepatitis C Transmission in Injection Drug Users: Could Swabs Be the Main Culprit?
Thibault V, Bara JL, Nefau T, Duplessy-Garson C.
J Infect Dis. 2011 Oct 19
 Abstract

Mathematically modelling the spread of hepatitis C in injecting drug users.
Corson S, Greenhalgh D, Hutchinson S.
Math Med Biol. 2011 Sep 6
 Abstract

Low risk for hepatitis C seroconversion in methadone maintenance treatment.
Peles E, Schreiber S, Rados V, Adelson M.
J Addict Med. 2011 Sep;5(3):214-20.
 Abstract

Multicentric Castleman's Disease in a Hepatitis C-Positive Intravenous Drug User: A Case Report.
Talukder DY, Delpachitra SN.
Case Report Med. 2011;2011:567840.
Abstract

Chronic pain and hepatitis C virus infection in opioid dependent injection drug users.
Tsui JI, Herman DS, Kettavong M,  et al
J Addict Dis. 2011 Apr;30(2):91-7
 Abstract

Survival of Hepatitis C Virus in Syringes: Implication for Transmission among
Injection Drug Users.
Paintsil E, He H, Peters C, et al .
J Infect Dis. 2010 Aug 20
 Abstract

Reinfection with hepatitis C virus following sustained virological response in injection drug users.
Grebely J, Knight E, Ngai T, et al 
J Gastroenterol Hepatol. 2010 Jul;25(7):1281-1284.
 Abstract

Characteristics of chronic hepatitis C among intravenous drug users:
a comparative analysis.
Jovanovic M, Jovanovic B, Potic M,  et al
Bosn J Basic Med Sci. 2010 May;10(2):153-7.
 Abstract

Hepatitis C virus recombinants are rare even among intravenous drug users.
Viazov S, Ross SS, Kyuregyan KK, et al
J Med Virol. 2010 Feb;82(2):232-8.
 Abstract

Can hepatitis C virus prevalence be used as a measure of injection-related human
immunodeficiency virus risk in populations of injecting drug users? An ecological
analysis.
Vickerman P, Hickman M, May M, et al 
Addiction. 2009 Nov 17.
 Abstract

A WEEK IN REVIEW FEATURED REPORT
Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area
injection drug users.
Burt RD, Thiede H, Hagan H.  
Drug Alcohol Depend. 2009 Aug 29.
 Abstract

Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection:
a population-based cohort study.
Omland LH, Jepsen P, Weis N, et al
J Viral Hepat. 2009 Aug 26
 Abstract

Protective KIR-HLA interactions for HCV infection in intravenous drug users.
Zúñiga J, Romero V, Azocar J, et al
Mol Immunol. 2009 Jun 22.
Abstract

High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.
Zule WA, Bobashev G.
Drug Alcohol Depend. 2008 Nov 10.
 Abstract

Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection:
The Influence of Time and Place.
Hagan H, Pouget ER, Des Jarlais DC, Lelutiu-Weinberger C.,et al 
Am J Epidemiol. 2008 Oct 9.
 Abstract
 
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained
virological response rates in adherent patients.
Bruggmann P, Falcato L, Dober S,et al
J Viral Hepat. 2008 Jul 10.
Abstract
 
Limited uptake of hepatitis C treatment among injection drug users.
Mehta SH, Genberg BL, Astemborski J,et al  
J Community Health. 2008 Jun;33(3):126-33
 Abstract
 
Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting
drug user.
Aitken CK, Tracy SL, Revill P, 
J Clin Virol. 2008 Jan 30
Abstract
 
A prospective study to examine persistent HCV reinfection in injection drug users who
have previously cleared the virus.
Currie SL, Ryan JC, Tracy D,et al  
Drug Alcohol Depend. 2007 Oct 29;
Abstract
 
Rethinking Approaches to Risk Reduction for Injection Drug Users: Differences in Drug
Type Affect Risk for HIV and Hepatitis C Virus Infection Through Drug-Injecting Networks.
De P, Cox J, Boivin JF, Platt RW, Jolly AM  .
J Acquir Immune Defic Syndr. 2007 Aug 23;
 Abstract
 
The Association of Human Immunodeficiency Virus Infection with Spontaneously Resolved
Hepatitis C Virus Infection and Level of Viremia Among Injection Drug Users.
 Seal KH, Monto A, Dove L, et al  
Dig Dis Sci. 2007 Apr 19;
 Abstract
 
Offers of Hepatitis C Care Do Not Lead to Treatment.
Schackman BR, Teixeira PA, Beeder AB
J Urban Health. 2007 Mar 30;
 Abstract
 
Hepatitis C Treatment Candidacy and Outcomes Among 4318 US Veterans With Chronic
Hepatitis C Virus Infection: Does a History of Injection Drug Use Matter?
Seal KH, Currie SL, Shen H
J Clin Gastroenterol. 2007 Feb;41(2):199-205.
 Abstract
 
Drug abuse, innate immunity and hepatitis C virus.
 Zhang T, Li Y, Ho WZ.   
Rev Med Virol. 2006 Aug 25;16(5):311-327
 Abstract
 
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C
infection among a cohort of injecting drug users.
Amin J, Law MG, Micallef J, Jauncey M, et al
Epidemiol Infect. 2006 May 17;:1-7
 Abstract
 
Injection Drug Use Is an Independent Risk Factor for Iron Deficiency and Iron Deficiency
Anemia Among HIV-Seropositive and HIV-Seronegative Women.
Dancheck B, Tang AM, Thomas AM, et al 
J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):198-20
 Abstract
 
The impact of barriers to hepatitis C virus treatment in recovering heroin users
maintained on methadone.
Sylvestre DL, Litwin AH, Clements BJ, Gourevitch MN.  
J Subst Abuse Treat. 2005 Oct;29(3):159-65
 Abstract
 
The hepatitis C virus epidemic among injecting drug users.
Pybus OG, Cochrane A, Holmes EC, Simmonds P.
Infect Genet Evol. 2005 Mar;5(2):131-9.
 Abstract
 
          Conference Reports, Abstracts, and Posters
 
  Survival of HCV in Syringes: Implication for HCV Transmission among Injection Drug Users
E Paintsil, H He, C Peters, et al
(17 CROI)
 Abstract
Pathogenesis
       
         Journal Papers, Abstracts, and Commentaries
 
 
Change in hepatitis C virus genotype in injecting drug users.
Aitken C, McCaw R, Jardine D,  
J Med Virol. 2004 Oct 13;74(4):543-545
Abstract 
 
Second infection with a different hepatitis C virus genotype in a intravenous
drug user during interferon therapy.
Asselah T, Vidaud D, Doloy A, et al.
Gut 2003 Jun;52(6):900-2
 Abstract 

Hepatitis C Virus Seroconversion among Young Injection Drug Users:
Relationships and Risks.
Hahn JA, Page-Shafer K, Lum PJ, et al.  
J Infect Dis 2002 Dec 1;186(11):1558-64
 Abstract

Injection drug use facilitates hepatitis C virus infection of peripheral blood
mononuclear cells.
Resti M, Azzari C, Moriondo M, et al.
Clin Infect Dis 2002 Aug 1;35(3):236-9
 Abstract

  
Prevention
       
         Journal Papers, Abstracts, and Commentaries
 
 
Evidence for the effectiveness of sterile injecting equipment provision in
preventing hepatitis C and human immunodeficiency virus transmission
among injecting drug users: a review of reviews.
Palmateer N, Kimber J, Hickman M, et al
Addiction. 2010 Mar 2.
Abstract

Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use,
injection drug use, and sexual risk behaviors among injection drug users
Zule WA, Costenbader EC, Coomes CM, Wechsberg WM. 
Am J Public Health. 2009 Apr;99 Suppl 1:S180-6.
Abstract 
 
Development, description, and acceptability of a small-group, behavioral intervention
to prevent HIV and hepatitis C virus Infections among young adult injection drug users.
Purcell DW, Garfein RS, Latka MH, et al
Drug Alcohol Depend. 2007 Apr 25;
Abstract 

WEEK-IN-REVIEW FEATURED REPORT
A Review of the Evidence for the Effectiveness of Primary Prevention Interventions for
Hepatitis C Among Injecting Drug Users.
Wright NM, Tompkins CN.
Harm Reduct J. 2006 Sep 6;3(1):27
 Abstract 
 
'It's Your Life!': Injecting Drug Users, Individual Responsibility and Hepatitis C
Prevention.
Fraser S. 
Health (London). 2004 Apr;8(2):199-221.
 Abstract 

Prevention and treatment of hepatitis C in injection drug users.
Edlin BR.
Hepatology 2002 Nov;36(5 Suppl):S210-9
 Abstract 

Screening/Testing
       
          Journal Papers, Abstracts, and Commentaries
 
Diagnostics/Monitoring/Screening/Testing
       

          Journal Papers, Abstracts, and Commentaries

 
Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.
Jewett A, Smith BD, Garfein RS, et al
J Clin Virol. 2012 May 3.
 Abstract

Early IL-10 predominant responses are associated with progression to chronic
hepatitis C virus infection in injecting drug users.
Flynn JK, Dore GJ, Hellard M,  et al
J Viral Hepat. 2010 Jul 5
 Abstract

Failure to diagnose recent hepatitis C virus infections in London injecting
drug users.
Aarons E, Grant P, Soldan K, et al 
Med Virol. 2004 Aug;73(4):548-53.
 Abstract

Finding a vein or obtaining consent: a qualitative study of hepatitis C
testing in GP methadone clinics.
Perry M, Chew-Graham C.
Fam Pract. 2003 Oct;20(5):538-44
 Abstract
Clinical Management
Drugs      

           Journal Papers, Abstracts, and Commentaries
 
 
Utility of the Beck Depression Inventory to screen for and track depression in injection
drug users seeking hepatitis C treatment.
Holtzheimer PE, Veitengruber J, Wang CC, et al
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):426-32.
 Abstract

Optimal targeting of Hepatitis C virus treatment among injecting drug users
to those not enrolled in methadone maintenance programs.
Zeiler I, Langlands T, Murray JM, et al
Drug Alcohol Depend. 2010 Apr 27
 Abstract

Determinants of successful chronic hepatitis C case finding among patients receiving
opioid maintenance treatment in a primary care setting.
Senn O, Seidenberg A, Rosemann T. 
Addiction. 2009 Dec;104(12):2033-2038
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
 Effective treatment of injecting drug users with recently acquired Hepatitis C virus infection.
Dore GJ, Hellard M, Matthews G, Grebely J, et al
Gastroenterology. 2009 Sep 23.
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence.
Hellard M, Sacks-Davis R, Gold J.
Clin Infect Dis. 2009 Jul 9.
 Abstract

Factors associated with treatment failure of patients with psychiatric diseases
and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic
infection.
Alvarez-Uria G, Day JN, Nasir AJ, et al
Liver Int. 2009 Aug;29(7):1051-5.
 Abstract

Predictors of treatment for hepatitis C virus (HCV) infection in drug users.
Reed C, Stuver SO, Tumilty S,  et al   
Subst Abus. 2008;29(1):5-15.
 Abstract
 
Critical issues in the treatment of hepatitis C virus infection in methadone maintenance
patients.
Novick DM, Kreek MJ. 
Addiction. 2008 Apr 16
Abstract
 
Liver transplant and hepatitis C in methadone maintenance therapy: a case report.
Hancock MM, Prosser CC, Ransibrahmanakul K, et al 
Subst Abuse Treat Prev Policy. 2007 Feb 1;2(1):5
Abstract
 
Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous
naltrexone implants.
 Jeffrey GP, MacQuillan G, Chua F, et al 
Hepatology. 2007 Jan;45(1):3-5.
 Abstract
 
fA WEEK-IN-REVIEW FEATURED REPORT
Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous
naltrexone implants.
 Jeffrey GP, Macquillan G, Chua F, et al
Hepatology. 2006 Dec 22;45(1):111-117
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL TEXT PDF ARTICLE
 Therapeutic challenges in hepatitis C-infected injection drug using patients.
Cooper CL, Mills EJ.
Harm Reduct J. 2006 Nov 10;3(1):31
Paper

 Acceptability of hepatitis C virus testing methods among injecting drug users.
White B, Day C, Thein HH, et al
 Drug Alcohol Rev. 2008 Mar 31:1-5.
 Abstract

Screening for Hepatitis C in injecting drug users: a cost utility analysis.
Stein K, Dalziel K, Walker A, et al    
J Public Health Med. 2004 Mar;26(1):61-71.
 Abstract

 
Guidelines for the treatment of hepatitis C virus infection in injection drug users: status
quo in the European union countries.
Reimer J, Schulte B, Castells X, et al 
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S373-8
 Abstract
 
Factors associated with interest in initiating treatment for hepatitis C Virus (HCV)
infection among young HCV-infected injection drug users.
Strathdee SA, Latka M, Campbell J, et al 
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S304-12
 Abstract
 
Factors Associated with Interest in Initiating Treatment for Hepatitis C Virus (HCV)
Infection among Young HCV-Infected Injection Drug Users.
 Strathdee SA, Latka M, Campbell J, et al   
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S304-12.
Abstract
 
Injection Drug Use and the Hepatitis C Virus: Considerations for a Targeted
Treatment Approach--The Case Study of Canada.
Fischer B, Haydon E, Rehm J, et al.
J Urban Health. 2004 Sep;81(3):428-447.
 Abstract  

Treating hepatitis C in methadone maintenance patients: an interim analysis.
Sylvestre DL.
Drug Alcohol Depend 2002 Jul 1;67(2):117-23
Abstract  
 
Severity and correlates of liver disease in hepatitis C virus-infected injection
drug users.
Rai R, Wilson LE,  Astemborski J, et al.
Hepatology 2002 May;35(5):1247-125
 Abstract 
  
Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years' Follow-Up .
Dalgard O, Bjoro K, Hellum K , et al.
Eur Addict Res 2002 Jan;8(1):45-49
 Abstract

Treatment of hepatitis C infection in injection drug users.
Backmund M, Meyer K, Von Zielonka M, Eichenlaub D.
 Hepatology 2001 Jul;34(1):188-93
 Abstract
 
Managing chronic hepatitis C acquired through intravenous drug use.
Jowett SL, Agarwal K, Smith BC, et al.
QJM 2001 Mar;94(3):153-8
 Abstract   
 

 
          Conference Reports, Abstracts, and Posters
 
  CONFERENCE PRESENTATION
 Injection Drug Use and Hepatitis
 Edlin BR
 NIH Consensus Development Conference on  Management of Hepatitis C: 2002]
 Report
 
 

IDU Disease Main Page Main New/Newsworthy  Home Page

IDU Health: Hepatitis C